Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region

PLoS One. 2013;8(1):e53326. doi: 10.1371/journal.pone.0053326. Epub 2013 Jan 11.

Abstract

Arasin 1 is a 37 amino acid long proline-rich antimicrobial peptide isolated from the spider crab, Hyas araneus. In this work the active region of arasin 1 was identified through structure-activity studies using different peptide fragments derived from the arasin 1 sequence. The pharmacophore was found to be located in the proline/arginine-rich NH(2) terminus of the peptide and the fragment arasin 1(1-23) was almost equally active to the full length peptide. Arasin 1 and its active fragment arasin 1(1-23) were shown to be non-toxic to human red blood cells and arasin 1(1-23) was able to bind chitin, a component of fungal cell walls and the crustacean shell. The mode of action of the fully active N-terminal arasin 1(1-23) was explored through killing kinetic and membrane permeabilization studies. At the minimal inhibitory concentration (MIC), arasin 1(1-23) was not bactericidal and had no membrane disruptive effect. In contrast, at concentrations of 5×MIC and above it was bactericidal and interfered with membrane integrity. We conclude that arasin 1(1-23) has a different mode of action than lytic peptides, like cecropin P1. Thus, we suggest a dual mode of action for arasin 1(1-23) involving membrane disruption at peptide concentrations above MIC, and an alternative mechanism of action, possibly involving intracellular targets, at MIC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents / chemistry*
  • Anti-Infective Agents / pharmacology*
  • Antifungal Agents / chemistry
  • Antifungal Agents / pharmacology
  • Antimicrobial Cationic Peptides / chemistry*
  • Antimicrobial Cationic Peptides / pharmacology*
  • Cell Membrane Permeability / drug effects
  • Chitin / metabolism
  • Circular Dichroism
  • Escherichia coli / drug effects
  • Hemolysis / drug effects
  • Humans
  • Kinetics
  • Microbial Sensitivity Tests
  • Microbial Viability / drug effects
  • Molecular Sequence Data
  • Peptide Fragments / chemistry
  • Peptide Fragments / pharmacology
  • Peptides / chemistry
  • Peptides / pharmacology
  • Proline-Rich Protein Domains
  • Structure-Activity Relationship

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Antifungal Agents
  • Antimicrobial Cationic Peptides
  • Peptide Fragments
  • Peptides
  • arasin 1, Hyas araneus
  • Chitin
  • cecropin P1-LI

Grants and funding

The present work was supported by the Norwegian Research Council (project number 184688/S40) (http://www.forskningsradet.no/servlet/Satellite?c=Page&cid=1177315753906&p=1177315753906&pagename=ForskningsradetEngelsk%2FHovedsidemal), grants from the University of Tromsø (http://uit.no/startsida) and the regional FUGE-N (Functional genomics in Norway, the Norwegian Research Council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.